Barclays PLC Common Stock (BCS)

Total Costs & Expenses

£29.81B

TTM · Period ending: · GBP

BCS logo

BCS Total Costs & Expenses

Latest reported£29.81B GBP
BCS TTM Total Costs & Expenses · GBP (£0.00 → £29.81B)
High-resolution chart · PNG

BCS total costs & expenses history

Trailing twelve months (TTM) · GBP. Each value covers four complete reported quarters.

Barclays PLC Common Stock Total Costs & Expenses — Trailing twelve months (TTM) (GBP)
Period endingTotal Costs & Expenses (GBP)
29,806,914,000
19,351,550,000
18,929,987,000
19,086,206,982
18,599,478,982
18,541,847,982
18,309,083,982
18,496,947,894
18,911,339,894
18,755,861,894
18,691,646,894
17,470,206,000
17,865,116,000
16,294,910,000
15,014,738,000
14,249,129,621
12,801,296,621
12,921,568,621
13,204,576,621
13,917,525,285
14,486,169,995
16,662,302,479
18,665,061,569
18,466,921,136
16,574,978,175
15,626,433,691
13,688,880,601
14,332,405,832
15,821,489,083
15,640,222,083
13,689,629,096
9,147,510,013
5,476,380,013
1,673,466,013
0
660,050,458
1,458,805,972
4,799,805,972
9,047,805,972
12,896,755,514
15,977,000,000
15,832,000,000
16,177,000,000
15,755,000,000
16,718,000,000
18,841,000,000
19,205,000,000
18,031,000,000
16,974,000,000
18,491,000,000
19,482,000,000
21,247,000,000
22,817,000,000
21,994,000,000
21,123,000,000
22,106,000,000
23,088,000,000
21,917,000,000
22,731,000,000
18,760,000,000
23,086,000,000
23,096,000,000
18,548,692,000
18,185,711,000
8,384,854,000
4,391,568,000
3,048,477,650
2,825,680,650
3,515,327,650
3,738,823,650
4,871,729,000
4,899,091,000
6,811,935,000
6,882,131,000
6,905,889,000
6,835,622,000
8,338,766,000
7,986,465,000
7,600,200,000
7,312,703,000
3,286,355,000
3,342,820,000
3,247,288,000
3,154,638,000
2,905,880,000
2,739,638,000
2,506,632,000
2,382,453,000
2,310,461,000
2,236,453,000
2,404,901,000
2,452,917,000
2,484,081,000
2,521,917,000
2,473,350,000
2,425,330,000
2,433,198,000
2,439,330,000
2,437,430,000
2,409,774,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.